Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.400.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.537NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.548NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.24.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.492NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.540NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.118NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.501NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.226NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.546NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.194NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.9 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.203NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.157NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.176NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.391NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.432NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.388NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.112NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.274NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.450NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.444NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.485NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.276NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.430NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.331NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.112.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used